Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
- Posted on April 20, 2026
- By CNBC
- 0 Views
- 1 min read
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.
